cancer

Almost 50 Non-Oncology Drugs Found to Kill Cancer Cells
Almost 50 Non-Oncology Drugs Found to Kill Cancer Cells
BioSpace
Broad Institute
Harvard
cancer
oncology
drug repurposing
Flag link:
BeiGene lung cancer treatment meets main goal in late-stage study
BeiGene lung cancer treatment meets main goal in late-stage study
Reuters
BeiGene
cancer
lung cancer
clinical trials
tislelizumab
Flag link:
I Have a Dream… Five Dreams for Biotech
I Have a Dream… Five Dreams for Biotech
BioSpace
biotech
patients
Alzheimer's disease
ALS
HIV
cancer
drug pricing
Flag link:
JPM: Biotech, VC execs on where the industry should look beyond cancer
JPM: Biotech, VC execs on where the industry should look beyond cancer
Fierce Biotech
oncology
cancer
Alzheimer's disease
diabetes
venture capital
JPMHC 2020
Flag link:
After closing one of China's biggest-ever raises, I-Mab Biopharma nabs $104M Nasdaq IPO
After closing one of China's biggest-ever raises, I-Mab Biopharma nabs $104M Nasdaq IPO
Fierce Biotech
IPOs
China
NASDAQ
I-Mab Biopharma
autoimmune disease
cancer
Flag link:
Tumour-agnostic drugs ‘game-changing’, says NICE as it rejects one from Bayer
Tumour-agnostic drugs ‘game-changing’, says NICE as it rejects one from Bayer
Pharmaforum
cancer
UK
NICE
Bayer
Vitrakvi
drug pricing
Flag link:
Why Johnson & Johnson Will Survive its Latest Litigation Wave
Why Johnson & Johnson Will Survive its Latest Litigation Wave
Motley Fool
JNJ
Risperdal
cancer
Flag link:
FDA Warns of Potential Cancer Risk With Weight Loss Drug
FDA Warns of Potential Cancer Risk With Weight Loss Drug
RAPS.org
FDA
Belviq
Eisai
cancer
Flag link:
Pfizer and eFFECTOR Ink $507 Million Cancer Deal
Pfizer and eFFECTOR Ink $507 Million Cancer Deal
BioSpace
Pfizer
Effector
small molecule drugs
cancer
drug development
Flag link:
At 2020 deadline, progress in Patrick Soon-Shiong’s ‘cancer moonshot’ is hard to find
At 2020 deadline, progress in Patrick Soon-Shiong’s ‘cancer moonshot’ is hard to find
Stat
Dr. Patrick Soon-Shiong
cancer
clinical trials
Flag link:
US cancer death rate drops by sharpest rate on record
US cancer death rate drops by sharpest rate on record
BioPharma Dive
cancer
Bristol-Myers Squibb
Yervoy
Merck
Keytruda
Flag link:
Verastem pens KRAS-focused drug licensing deal with Chugai
Verastem pens KRAS-focused drug licensing deal with Chugai
Fierce Biotech
Verastem
KRAS
cancer
Chugai
Flag link:
Drug developers take fresh aim at 'guided-missile' cancer drugs
Drug developers take fresh aim at 'guided-missile' cancer drugs
Reuters
cancer
oncology
drug development
antibody-drug conjugate
Flag link:
The first biotech IPO of the new decade has landed — and of course it's another cancer drug developer
The first biotech IPO of the new decade has landed — and of course it's another cancer drug developer
Endpoints
Black Diamond Therapeutics
IPOs
oncology
cancer
I-Mab Biopharma
Flag link:
3 Blockbuster Cancer Drug Launches to Watch in 2020
3 Blockbuster Cancer Drug Launches to Watch in 2020
Motley Fool
FDA
drug approvals
cancer
drug launches
AstraZeneca
Enhertu
Padcev
Seattle Genetics
BeiGene
Brukinsa
Flag link:
Takeda Strikes Potential $1 Billion Oncology Deal with Turnstone
Takeda Strikes Potential $1 Billion Oncology Deal with Turnstone
BioSpace
Takeda
Turnstone Biologics
RIVAL-01
cancer
oncology
Flag link:
When FDA Requires Pediatric Studies for New Cancer Drug Submissions: New Draft Guidance
When FDA Requires Pediatric Studies for New Cancer Drug Submissions: New Draft Guidance
RAPS.org
FDA
cancer
oncology
pediatric cancer
pediatric
Flag link:
Vedanta Biosciences initiates first-in-patient study of VE800 in combination with Bristol-Myers Squibb’s Opdivo
Vedanta Biosciences initiates first-in-patient study of VE800 in combination with Bristol-Myers Squibb’s Opdivo
Pharmaceutical Business Review
Vedanta Biosciences
VE800
Bristol-Myers Squibb
Opdivo
cancer
clinical trials
Flag link:
AbbVie and Scripps Research Enter Research Partnership in Cancer, Immunology, Neurology and Fibrosis
AbbVie and Scripps Research Enter Research Partnership in Cancer, Immunology, Neurology and Fibrosis
BioSpace
AbbVie
Scripps Research Institute
cancer
immunology
fibrosis
Flag link:
ASH19: AZ’s Calquence throws gauntlet down to Imbruvica
ASH19: AZ’s Calquence throws gauntlet down to Imbruvica
Pharmaforum
AstraZeneca
cancer
Calquence
ASH2019
Imbruvica
JNJ
AbbVie
CLL
Flag link:

Pages